Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

OsseoSpeed TX 3.5S - 11 mm: medical device reports filed with FDA

6,287 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

6,287
device reports naming the brand
0% of all MAUDE reports · about 888 a year
769
reports, 12 months to August 2026
854 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 6,287 reports that name the brand "OsseoSpeed TX 3.5S - 11 mm" (implant endosseous root-form), received between June 2019 and August 2026; the manufacturer given most often on reports is Dentsply Implants Manufacturing. Spellings of one product vary from report to report.

769 reports arrived in the 12 months to August 2026, down 10% from 854 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are osseointegration problem (37%), failure to osseointegrate (30.5%) and loss of osseointegration (27.9%). The patient problems coded most often are failure of implant, inflammation and osteolysis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

065129Sep 2021: 41Oct 2021: 50Nov 2021: 78Dec 2021: 762022Jan 2022: 73Feb 2022: 55Mar 2022: 89Apr 2022: 120May 2022: 81Jun 2022: 71Jul 2022: 53Aug 2022: 80Sep 2022: 50Oct 2022: 74Nov 2022: 79Dec 2022: 772023Jan 2023: 76Feb 2023: 57Mar 2023: 85Apr 2023: 42May 2023: 71Jun 2023: 78Jul 2023: 74Aug 2023: 97Sep 2023: 106Oct 2023: 70Nov 2023: 80Dec 2023: 442024Jan 2024: 70Feb 2024: 87Mar 2024: 68Apr 2024: 93May 2024: 49Jun 2024: 118Jul 2024: 105Aug 2024: 93Sep 2024: 76Oct 2024: 62Nov 2024: 90Dec 2024: 512025Jan 2025: 66Feb 2025: 51Mar 2025: 129Apr 2025: 40May 2025: 42Jun 2025: 73Jul 2025: 98Aug 2025: 76Sep 2025: 74Oct 2025: 63Nov 2025: 60Dec 2025: 832026Jan 2026: 74Feb 2026: 45Mar 2026: 62Apr 2026: 49May 2026: 55Jun 2026: 64Jul 2026: 90Aug 2026: 50

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01,0072,0142019: 18520192021: 2,01420212022: 90220222023: 88020232024: 96220242025: 85520252026: 4892026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%6,285
Malfunction0%2
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%6,287
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Osseointegration problem2,32937%7.7%
Failure to osseointegrate1,91730.5%62.8%
Loss of osseointegration1,75627.9%22.4%
Fracturea broken bone3084.9%1.6%
Crackthe device cracked310.5%0%
Loosening of implant not related to bone-ingrowth240.4%0.1%
Damaged thread70.1%0%
Insufficient device problem information60.1%0.2%
Off-label use60.1%0%
Malposition of device30%0.1%
Patient-device incompatibilitythe device did not suit the patient20%0%
Device dislodged or dislocated10%0%
Migration or expulsion of device10%0%
Overfill10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant6,27099.7%
Inflammationinflammation86213.7%
Osteolysis3515.6%
Pocket erosion3355.3%
Inadequate osseointegration100.2%
Implant pain90.1%
Abscessa collection of pus20%
Discomfortdiscomfort20%
Erosion20%
Hypersensitivity/allergic reaction20%
Painpain, site not specified20%
Deformity/ disfigurement10%
Necrosisdeath of tissue10%
Numbnessnumbness10%
Paresthesia10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureOsseoSpeed TX 3.5S - 11 mmProduct code DZEAll MAUDE reports
Reports6,2873,924,24126,136,888
Share of that pool—0.2%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about OsseoSpeed TX 3.5S - 11 mm reports

How many FDA reports name OsseoSpeed TX 3.5S - 11 mm?

6,287 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 769 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

osseointegration problem (37%), failure to osseointegrate (30.5%), loss of osseointegration (27.9%), fracture (4.9%) and crack (0.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that OsseoSpeed TX 3.5S - 11 mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.